The eligibility for duty-free treatment under subheading 9817.00.96, HTSUS, of TCC-EZ® Total Contact Cast System from an unidentified country
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated March 31, 2025, you requested a tariff classification ruling on the TCC-EZ® Total Contact Cast System. TCC-EZ® Total Contact Cast System is said to be a specialized offloading device (a synthetic mesh cast supported by a cast boot) designed to provide a protective wound healing environment for diabetic foot ulcers (DFUs). It consists primarily of a stockinette, a felt padding, a white protective sleeve, a cast sock, and a customized cast boot.
The system offloads the wound, reducing pressure and shear force, promoting healing, and protecting the affected limb from further trauma. A Total Contact Cast (TCC) is a cast used to help promote healing by minimizing pressure and shear force at the wound site. TCCs are used to treat patients suffering from diabetic foot ulcers (non-infected neuropathic foot ulcers), charcot neuroarthropathy, or for post operative surgical site protection.
According to the submitted documents, the TCCs have demonstrated a wound healing (wound closure) rate of 88 percent of DFUs in 43 days and is recognized as the Gold Standard treatment for healing DFUs. The TCC-EZ® decreases the time of cast application compared to standard TCCs and makes applying and wearing a TCC easier.
In your submission you requested consideration of a classification under subheading 9817.00.96, Harmonized Tariff Schedule of the United States (“HTSUS”) which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “[a]rticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: [o]ther.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
Subheading 9817.00.96, HTSUS, excludes “(i) articles for acute or transient disability; (ii) spectacles, dentures, and cosmetic articles for individuals not substantially disabled; (iii) therapeutic and diagnostic articles; or, (iv) medicine or drugs.” U.S. Note 4(b), Subchapter XVII, Chapter 98, HTSUS. U.S. Customs and Border Protection (“CBP”) and the courts have held that therapeutic articles within the context of this provision are those articles that heal or cure a condition. See T.D. 92-77, 26 Cust.
B. & Dec. 240, 241 (1992); Travenol Laboratories, Inc. v. U.S., 17 CIT 69, (1993). Also, the courts and CBP have consistently held that therapeutic articles are articles whose purpose is the “complete or partial elimination of disease.” See Headquarters Ruling Letter (“HQ”) H285358, dated August 6, 2018. You state that “Diabetic foot ulcers ...
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N347220).